Freo Ulderico, Ori Carlo
Department of Pharmacology and Anesthesiology, Padova University, Padova, Italy.
Anesthesiology. 2004 May;100(5):1172-8. doi: 10.1097/00000542-200405000-00020.
Unlike most anesthetics, ketamine racemate (S, R (+/-)-ketamine) induces heterogenous changes in cerebral metabolism. S, R (+/-)-ketamine is an equimolar mixture of two enantiomers, S (+)-ketamine and R (-)-ketamine, which differ in affinity for neuroreceptors and pharmacologic activities. This study investigated comparatively the effects of ketamine racemate and enantiomers on cerebral metabolism.
Regional cerebral metabolic rates for glucose (rCMRglc) were determined with the quantitative, autoradiographic [C]2-deoxy-d-glucose technique in 40 brain regions of Fischer-344 rats. rCMRglc were measured in three groups of rats during equimolar anesthesia, 10 min after intraperitoneal injection of 170 mg/kg S, R (+/-)-ketamine, S (+)-ketamine, or R (-)-ketamine; in three groups of rats during recovery from equivalent anesthesia, 20 min after intravenous injection of 20, 12.5, and 30 mg/kg S, R (+/-)-ketamine, S (+)-ketamine, or R (-)-ketamine; and in two groups of saline-injected control rats.
S, R (+/-)-ketamine and S (+)-ketamine induced a sustained anesthesia; deep rCMRglc decreases in 22 and 14 cortical, thalamic, cerebellar, and brainstem regions; and rCMRglc increases in two limbic regions (average decreases, 23 and 15%). R (-)-ketamine determined a shorter anesthesia, lesser rCMRglc decreases in 11 brain areas, and marked rCMRglc increases in 14 basal ganglia and limbic regions (average decrease, 4%). S, R (+/-)-ketamine, S (+)-ketamine, and R (-)-ketamine all produced postanesthetic behavioral activation; widespread rCMRglc increases in 28, 16, and 20 cortical, thalamic, basal ganglia, limbic, and brainstem regions; and rCMRglc decreases in few auditory and limbic regions (average increases, 35, 13, and 20%).
S, R (+/-)-ketamine and S (+)-ketamine anesthesia but not R (-)-ketamine anesthesia induced widespread rCMRglc reductions that were unreported but are typical of gaseous and intravenous general anesthetics. Postanesthetic recovery led to divergent, sharp behavioral and rCMRglc activations. The relation to dose of behavioral and rCMRglc effects differs from those of aminergic agents and resembles those of N-methyl-d-aspartate receptor antagonists, suggesting that ketamine racemate and enantiomers may preferentially interact with this receptor type.
与大多数麻醉剂不同,消旋氯胺酮(S,R(+/-)-氯胺酮)会引起大脑代谢的异质性变化。S,R(+/-)-氯胺酮是两种对映体S(+)-氯胺酮和R(-)-氯胺酮的等摩尔混合物,它们对神经受体的亲和力和药理活性不同。本研究比较了消旋氯胺酮及其对映体对大脑代谢的影响。
采用定量放射自显影[C]2-脱氧-D-葡萄糖技术,测定Fischer-344大鼠40个脑区的局部脑葡萄糖代谢率(rCMRglc)。在三组大鼠等摩尔麻醉期间、腹腔注射170mg/kg S,R(+/-)-氯胺酮、S(+)-氯胺酮或R(-)-氯胺酮10分钟后;在三组大鼠从等效麻醉恢复期间、静脉注射20、12.5和30mg/kg S,R(+/-)-氯胺酮、S(+)-氯胺酮或R(-)-氯胺酮20分钟后;以及在两组注射生理盐水的对照大鼠中测量rCMRglc。
S,R(+/-)-氯胺酮和S(+)-氯胺酮诱导持续麻醉;22个和14个皮质、丘脑、小脑和脑干区域的rCMRglc深度降低;两个边缘区域的rCMRglc升高(平均降低23%和15%)。R(-)-氯胺酮导致麻醉时间较短,11个脑区的rCMRglc降低较少,14个基底神经节和边缘区域的rCMRglc显著升高(平均降低4%)。S,R(+/-)-氯胺酮、S(+)-氯胺酮和R(-)-氯胺酮均产生麻醉后行为激活;28个、16个和20个皮质、丘脑、基底神经节、边缘和脑干区域的rCMRglc广泛升高;少数听觉和边缘区域的rCMRglc降低(平均升高35%、13%和20%)。
S,R(+/-)-氯胺酮和S(+)-氯胺酮麻醉而非R(-)-氯胺酮麻醉诱导了广泛的rCMRglc降低,这一现象此前未被报道,但却是气态和静脉全身麻醉剂的典型特征。麻醉后恢复导致行为和rCMRglc的激活出现差异且明显。行为和rCMRglc效应与剂量的关系不同于胺能药物,类似于N-甲基-D-天冬氨酸受体拮抗剂,这表明消旋氯胺酮及其对映体可能优先与这种受体类型相互作用。